Anti-apoptosis | 727 |
Cdc42 protein signal transduction | 53 |
Cell death | 254 |
CGMP-mediated signaling | 27 |
Cholesterol efflux | 92 |
Cholesterol homeostasis | 162 |
Chylomicron remnant clearance | 32 |
Cytoskeleton organization | 135 |
G-protein coupled receptor signaling pathway | 315 |
High-density lipoprotein particle assembly | 58 |
High-density lipoprotein particle clearance | 64 |
High-density lipoprotein particle remodeling | 84 |
Induction of apoptosis | 395 |
Intracellular transport | 37 |
Negative regulation of blood vessel endothelial cell migration | 49 |
Negative regulation of cholesterol biosynthetic process | 26 |
Negative regulation of endothelial cell proliferation | 73 |
Negative regulation of inflammatory response | 84 |
Negative regulation of MAP kinase activity | 109 |
Negative regulation of platelet activation | 62 |
Nitric oxide mediated signal transduction | 69 |
Phospholipid efflux | 83 |
Positive regulation of cGMP biosynthetic process | 17 |
Positive regulation of cholesterol efflux | 69 |
Positive regulation of cholesterol esterification | 75 |
Positive regulation of low-density lipoprotein particle receptor catabolic process | 17 |
Positive regulation of membrane protein ectodomain proteolysis | 87 |
Positive regulation of nitric-oxide synthase activity | 101 |
Receptor-mediated endocytosis | 92 |
Regulation of axon extension | 18 |
Regulation of neuronal synaptic plasticity | 24 |
Response to reactive oxygen species | 25 |
Reverse cholesterol transport | 103 |
Synaptic transmission, cholinergic | 52 |
Triglyceride metabolic process | 52 |
Very-low-density lipoprotein particle clearance | 19 |
Very-low-density lipoprotein particle remodeling | 37 |